| Ms Shaaron D Jackson, MA-CCC-SLP | |
|
915 4th Street Ne, Auburn School District, Auburn, Wa, WA 98002 | |
| (253) 931-4927 | |
| Not Available |
| Full Name | Ms Shaaron D Jackson |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 915 4th Street Ne, Auburn, Wa, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760732093 | NPI | - | NPPES |
| 01107304 | Other | WA | ASHA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
| Provider Name | Alaska Native Tribal Health Consortium |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437189339 PECOS PAC ID: 6709780265 Enrollment ID: O20031125000772 |
News Archive
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
Using a weak electric current in an attempt to boost brainpower or treat conditions has become popular among scientists and do-it-yourselfers, but a new University of North Carolina School of Medicine study shows that using the most common form of electric brain stimulation had a statistically significant detrimental effect on IQ scores.
"How is it we can run the country with a 16-page Constitution yet it takes 2,074 pages and more than 400,000 words of gobbledygook to present the Senate Health Care Bill?" asks Alan Siegel, one of the founders of the Plain English and Simplification movements and Chairman and CEO of brand consultancy Siegel+Gale.
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
› Verified 4 days ago
| Provider Name | Southcentral Foundation |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1780614263 PECOS PAC ID: 5496663627 Enrollment ID: O20051027000416 |
News Archive
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
Using a weak electric current in an attempt to boost brainpower or treat conditions has become popular among scientists and do-it-yourselfers, but a new University of North Carolina School of Medicine study shows that using the most common form of electric brain stimulation had a statistically significant detrimental effect on IQ scores.
"How is it we can run the country with a 16-page Constitution yet it takes 2,074 pages and more than 400,000 words of gobbledygook to present the Senate Health Care Bill?" asks Alan Siegel, one of the founders of the Plain English and Simplification movements and Chairman and CEO of brand consultancy Siegel+Gale.
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Shaaron D Jackson, MA-CCC-SLP 915 4th Street Ne, Auburn School District, Auburn, Wa, WA 98002 Ph: (253) 931-4927 | Ms Shaaron D Jackson, MA-CCC-SLP 915 4th Street Ne, Auburn School District, Auburn, Wa, WA 98002 Ph: (253) 931-4927 |
News Archive
ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.
Using a weak electric current in an attempt to boost brainpower or treat conditions has become popular among scientists and do-it-yourselfers, but a new University of North Carolina School of Medicine study shows that using the most common form of electric brain stimulation had a statistically significant detrimental effect on IQ scores.
"How is it we can run the country with a 16-page Constitution yet it takes 2,074 pages and more than 400,000 words of gobbledygook to present the Senate Health Care Bill?" asks Alan Siegel, one of the founders of the Plain English and Simplification movements and Chairman and CEO of brand consultancy Siegel+Gale.
Life Technologies Corporation today announced that it is the first life science tools provider entering clinical trials to prove the safety and effectiveness of their DNA sequence-based typing (SBT) platform for analysis of the Human Leukocyte Antigen (HLA) system. Submission for 510(k) clearance of this SBT platform will follow completion of the clinical trials, which is anticipated this summer.
› Verified 4 days ago